Goldman Sachs
STJ

Goldman Sachs’s St Jude Medical STJ Stock Holding History

Goldman Sachs’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-8,601,287
Closed -$690M – 7266
2016
Q4 		$690M Buy
8,601,287
+2,344,691
+37% +$186M 0.2% 74
2016
Q3 		$499M Buy
6,256,596
+737,014
+13% +$59.5M 0.15% 98
2016
Q2 		$431M Buy
5,519,582
+3,359,259
+155% +$240M 0.14% 115
2016
Q1 		$119M Buy
2,160,323
+1,449,530
+204% +$79M 0.04% 575
2015
Q4 		$43.9M Buy
710,793
+169,824
+31% +$10.7M 0.01% 1219
2015
Q3 		$34.1M Sell
540,969
-14,136
-3% -$1.01M 0.01% 1327
2015
Q2 		$40.6M Sell
555,105
-335,475
-38% -$24.2M 0.01% 1266
2015
Q1 		$58.2M Sell
890,580
-46,998
-5% -$3.13M 0.02% 989
2014
Q4 		$61M Buy
937,578
+42,710
+5% +$2.75M 0.02% 959
2014
Q3 		$53.8M Sell
894,868
-340,032
-28% -$22.2M 0.02% 1015
2014
Q2 		$85.5M Sell
1,234,900
-103,847
-8% -$6.73M 0.03% 753
2014
Q1 		$87.5M Buy
1,338,747
+164,676
+14% +$10.7M 0.03% 678
2013
Q4 		$72.7M Sell
1,174,071
-58,613
-5% -$3.39M 0.02% 799
2013
Q3 		$66.1M Sell
1,232,684
-492,721
-29% -$25.4M 0.02% 799
2013
Q2 		$78.7M Buy
+1,725,405
New +$74.8M 0.03% 649

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Goldman Sachs's STJ Position: Q1 2017 in Review

Goldman Sachs sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 8,601,287 shares — an estimated $690M sold.

Goldman Sachs first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $690M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Goldman Sachs reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Goldman Sachs sold 8,601,287 St Jude Medical shares in Q1 2017, an estimated $690M.
  • Goldman Sachs first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Goldman Sachs's St Jude Medical position peaked at $690M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.